Analytica Anacon India 2013 begins in Mumbai


Analytica Anacon India, a leading trade show and conference in analytical instruments industry, began today at Bombay Exhibition Centre. Organised jointly by MMI India and IAIA – Indian Analytical Instruments Association, the event will be held till November 14.

The event is a prominent platform for national and international analytical instrument manufacturers and suppliers to showcase their products and solutions. Currently in its 7th year, the event has received participation from leaders in the industry – Agilent Technologies, Borosil, Bruker AXS Analytical Instruments, Cryogen Instruments, Eppendorf, GCE India, GeneDireX, Horiba India, Hosokawa Micron, Inkarp Instruments, Labcon, LCGC Chrom Consumables, Marsap, Medispec Instruments, Merck Millipore, Metrohm India, Mettler Toledo, Phenomenex India, S.V.Scientific, Shimadzu Analytical, Skytech Systems, TA Instruments, Thermo Fisher Scientific and Waters India

Despite Indian analytical industry’s significant contribution to the overall growth of the economy and in food and environmental safety, there are many challenges being faced by the members of the industry.Addressing these concerns, this year’s Analytica Anacon India Conference has “Research & Regulations: Challenges for the Pharmaceutical, Life Science and Food Industries”. The conference is across November 12 and 13 inside the exhibition area.

Day 1 – Pharmaceuticals and Drug Discovery Research

First day of the conference witnessed insight-sharing from leading decision-makers in the industry. Dr Ashwini Sandu, head IPR, United Phosphorus, delivered a talk on analytical patents in India. While exploring legalities related to patents she said, “Earlier anything related to process or apparatus could not be filed for patent. Amendment in Indian Patent Act in 2005 made it possible to file patent for a process or an apparatus. This proved a very big change for the analytical industry in India.”

Dr Gerof Tittel, CEO, Dronanina, addressed the subject of genotoxic impurities in herbal medicinal products. “Depending upon the technique used for extraction or preparation, genetoxic principles or single compounds in plant material may be enriched or decreased. Genotoxic potential of herbal preparations needs to be assessed for application of marketing authorisation in the EU.”

K K Baghchandani, CEO, ACD Labs, exploring the topic from a managerial angle, explained importance of right information management in R&D to avoid loss of man hours and costs.

The day also witnessed talks on drug discovery research by Dr G Palit, CDRI, Prof Dr. B Buszewski, University Torun, Poland, Dr Vyas, Analytical R&D, Dr Reddy’s Labs, Prof. Dr O Schmitz, University Duisberg-Essen, Germany. The day ended with Dr K S Boos’ tutorial on setting up online SPE LC MS platform for direct analysis of drugs in body fluids. Dr K S Boos is professor at Medical Centre, LM University, Munich, Germany.

Read Previous

Partners in Health, Abbott and the Abbott Fund open nutrition facility in Haiti

Read Next

FCI to setup office in Guwahati for implementation of Food Security Act

Leave a Reply